Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome

被引:12
|
作者
Newman, N. K. [1 ]
Zhang, Y. [2 ,3 ]
Padiadpu, J. [1 ]
Miranda, C. L. [4 ]
Magana, A. A. [5 ]
Wong, C. P. [2 ]
Hioki, K. A. [1 ,6 ]
Pederson, J. W. [7 ]
Li, Z. [7 ]
Gurung, M. [7 ,8 ]
Bruce, A. M. [1 ]
Brown, K. [1 ,9 ]
Bobe, G. [10 ]
Sharpton, T. J. [11 ]
Shulzhenko, N. [7 ]
Maier, C. S. [5 ]
Stevens, J. F. [4 ]
Gombart, A. F. [12 ]
Morgun, A. [1 ]
机构
[1] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA
[2] Oregon State Univ, Linus Pauling Inst, Sch Biol & Populat Hlth Sci, Nutr Program, Corvallis, OR USA
[3] Oregon Hlth & Sci Univ, Portland, OR USA
[4] Oregon State Univ, Linus Pauling Inst, Dept Pharmaceut Sci, Corvallis, OR USA
[5] Oregon State Univ, Linus Pauling Inst, Dept Chem, Corvallis, OR USA
[6] UMass, Amherst, MA USA
[7] Oregon State Univ, Carlson Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA
[8] USDA, Children Nutr Ctr, Little Rock, AR USA
[9] Oregon State Univ, Chem Biol & Environm Engn, Corvallis, OR USA
[10] Oregon State Univ, Linus Pauling Inst, Dept Anim Sci, Corvallis, OR 97331 USA
[11] Oregon State Univ, Dept Microbiol, Dept Stat, Corvallis, OR USA
[12] Linus Pauling Inst, Dept Biochem & Biophys, Corvallis, OR 97331 USA
关键词
HUMULUS-LUPULUS L; LIPID-METABOLISM; XANTHOHUMOL; GLUCOSE; MACROPHAGES; MECHANISMS; OBESITY; HEALTH; HOST; HOP;
D O I
10.1186/s40168-023-01637-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
BackgroundThe gut microbiota contributes to macrophage-mediated inflammation in adipose tissue with consumption of an obesogenic diet, thus driving the development of metabolic syndrome. There is a need to identify and develop interventions that abrogate this condition. The hops-derived prenylated flavonoid xanthohumol (XN) and its semi-synthetic derivative tetrahydroxanthohumol (TXN) attenuate high-fat diet-induced obesity, hepatosteatosis, and metabolic syndrome in C57Bl/6J mice. This coincides with a decrease in pro-inflammatory gene expression in the gut and adipose tissue, together with alterations in the gut microbiota and bile acid composition.ResultsIn this study, we integrated and interrogated multi-omics data from different organs with fecal 16S rRNA sequences and systemic metabolic phenotypic data using a Transkingdom Network Analysis. By incorporating cell type information from single-cell RNA-seq data, we discovered TXN attenuates macrophage inflammatory processes in adipose tissue. TXN treatment also reduced levels of inflammation-inducing microbes, such as Oscillibacter valericigenes, that lead to adverse metabolic phenotypes. Furthermore, in vitro validation in macrophage cell lines and in vivo mouse supplementation showed addition of O. valericigenes supernatant induced the expression of metabolic macrophage signature genes that are downregulated by TXN in vivo.ConclusionsOur findings establish an important mechanism by which TXN mitigates adverse phenotypic outcomes of diet-induced obesity and metabolic syndrome. TXN primarily reduces the abundance of pro-inflammatory gut microbes that can otherwise promote macrophage-associated inflammation in white adipose tissue.7MrSGPEkxmDTc41cVX6rPoVideo AbstractConclusionsOur findings establish an important mechanism by which TXN mitigates adverse phenotypic outcomes of diet-induced obesity and metabolic syndrome. TXN primarily reduces the abundance of pro-inflammatory gut microbes that can otherwise promote macrophage-associated inflammation in white adipose tissue.7MrSGPEkxmDTc41cVX6rPoVideo Abstract
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome
    N. K. Newman
    Y. Zhang
    J. Padiadpu
    C. L. Miranda
    A. A. Magana
    C. P. Wong
    K. A. Hioki
    J. W. Pederson
    Z. Li
    M. Gurung
    A. M. Bruce
    K. Brown
    G. Bobe
    T. J. Sharpton
    N. Shulzhenko
    C. S. Maier
    J. F. Stevens
    A. F. Gombart
    A. Morgun
    Microbiome, 11
  • [2] Isoliquiritigenin Attenuates Adipose Tissue Inflammation and Metabolic Syndrome by Modifying Gut Bacteria Composition in Mice
    Ishibashi, Riko
    Furusawa, Yukihiro
    Honda, Hiroe
    Watanabe, Yasuharu
    Fujisaka, Shiho
    Nishikawa, Miyu
    Ikushiro, Shinichi
    Kurihara, Shin
    Tabuchi, Yoshiaki
    Tobe, Kazuyuki
    Takatsu, Kiyoshi
    Nagai, Yoshinori
    MOLECULAR NUTRITION & FOOD RESEARCH, 2022, 66 (10)
  • [3] Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
    Maury, E.
    Brichard, S. M.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 314 (01) : 1 - 16
  • [4] Antibiotic Treatment Alters the Gut Microbiome, Adipose Tissue Inflammation, and Energy Metabolism
    Fujisaka, Shiho
    Ussar, Siegfried
    Kahn, C. Ronald
    DIABETES, 2014, 63 : A497 - A497
  • [5] Gut microbiome-driven regulation of sex hormone homeostasis: a potential neuroendocrine connection
    Organski, Anna Clapp
    Rajwa, Bartek
    Reddivari, Anjali
    Jorgensen, Joan S.
    Cross, Tzu-Wen L.
    GUT MICROBES, 2025, 17 (01)
  • [6] Gut microbiome and metabolic syndrome
    Mazidi, Mohsen
    Rezaie, Peyman
    Kengne, Andre Pascal
    Mobarhan, Majid Ghayour
    Ferns, Gordon A.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2016, 10 (02) : S150 - S157
  • [7] The gut microbiome and metabolic syndrome
    Dabke, Kruttika
    Hendrick, Gustaf
    Devkota, Suzanne
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (10): : 4050 - 4057
  • [8] Characteristics of Abdominal Visceral Adipose Tissue, Metabolic Health and the Gut Microbiome in Adults
    U-Din, Mueez
    Ahmed, Basma A.
    Syed, Saad A.
    Ong, Frank J.
    Oreskovich, Stephan M.
    Gunn, Elizabeth
    Surette, Michael G.
    Punthakee, Zubin
    Steinberg, Gregory R.
    Morrison, Katherine M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (03): : 680 - 690
  • [9] Gut microbiome-driven exposure to anti-inflammatory dietary bioactives in humans
    Lampe, Johanna Wyss
    CANCER RESEARCH, 2014, 74 (19)
  • [10] A gut reaction: Microbiome-driven glycemic effects of non-nutritive sweeteners
    Page, Kathleen A.
    CELL, 2022, 185 (18) : 3282 - 3284